Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Receivables (2016 - 2025)

InspireMD's Receivables history spans 16 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Receivables rose 13.93% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 13.93%, while the annual FY2025 figure was $2.6 million, 13.93% up from the prior year.
  • Receivables reached $2.6 million in Q4 2025 per NSPR's latest filing, up from $2.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.6 million in Q4 2025 to a low of $825000.0 in Q1 2021.
  • Average Receivables over 5 years is $1.7 million, with a median of $1.7 million recorded in 2023.
  • The largest YoY upside for Receivables was 123.31% in 2021 against a maximum downside of 19.9% in 2021.
  • A 5-year view of Receivables shows it stood at $1.4 million in 2021, then dropped by 10.22% to $1.2 million in 2022, then surged by 96.63% to $2.5 million in 2023, then decreased by 8.08% to $2.3 million in 2024, then grew by 13.93% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Receivables are $2.6 million (Q4 2025), $2.4 million (Q3 2025), and $2.1 million (Q2 2025).